Viewing Study NCT05872620


Ignite Creation Date: 2025-12-25 @ 4:23 AM
Ignite Modification Date: 2026-04-12 @ 5:19 PM
Study NCT ID: NCT05872620
Status: COMPLETED
Last Update Posted: 2025-09-18
First Post: 2023-05-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Sponsor: Eli Lilly and Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module